Sleepose

Basic Sleepose information

• INN (international nonproprietary name): Melatonin (the active ingredient of Sleepose).
• ATC code: N05CH01
• Forms and dosages: Disintegrating tablet (DT) containing melatonin, likely 20 mg per tablet.
• Registration status in the United Kingdom: Not licensed in the UK
• OTC / Rx classification: Melatonin is a prescription-only medicine (POM) in the UK.

What Sleepose is

Core product details

Sleepose 20 Tablet DT is a disintegrating tablet formulation containing melatonin.

Available information indicates a likely 20 mg melatonin content per tablet, reflected in the product name Sleepose 20.

Melatonin is classified under ATC code N05CH01 and is used for sleep disturbances.

The DT format is intended to dissolve rapidly without water for easier administration and faster absorption compared with standard tablets.

Key facts include the active ingredient (melatonin), form (disintegrating tablet), strength (20 mg), storage (cool, dry) and common adverse effects such as drowsiness, headache and nausea.

Indications and practical use cases

Common uses

Sleepose is used mainly for short-term management of insomnia symptoms, delayed sleep phase, jet lag and stress-related sleep disruption.

Real-world use follows melatonin’s chronobiotic action and hypnotic properties.

Melatonin is generally used for circadian rhythm problems and short-term sleep-onset difficulties rather than chronic, untreated insomnia without medical review.

Practical scenarios

Travel and jet lag: take melatonin close to the target bedtime at the destination; dose timing depends on the direction of travel.

Shift work: use timed melatonin to promote daytime sleep where indicated, with advice on light exposure and sleep hygiene.

Short-term insomnia (acute stress): try the lowest effective dose for a limited period and review if sleep does not improve.

Immediate-release versus prolonged-release: immediate-release formulations suit sleep onset and prolonged-release formulations suit sleep-maintenance problems.

Individualise treatment: start at the lowest effective dose and consult the GP for ongoing sleep disturbance or suspected secondary causes such as depression or sleep apnoea.

How melatonin works

Pharmacological action

Melatonin is an endogenous hormone produced by the pineal gland that signals biological night and helps regulate circadian rhythms.

Exogenous melatonin, as found in Sleepose, acts on MT1 and MT2 receptors to shift circadian phase and reduce sleep latency.

The disintegrating tablet format suggests more rapid absorption compared with standard tablets, favouring a quicker onset of effect.

Onset, peak and duration

Onset is usually within 30–90 minutes, with peak concentration thereafter; duration depends on dose and formulation.

Higher doses such as 20 mg may prolong detectable melatonin levels and increase the risk of residual morning drowsiness compared with the lower doses commonly used in the UK.

Melatonin is best taken 30–60 minutes before the intended sleep time, avoiding daytime dosing unless specifically directed.

Dosage, administration and tablet features

Practical dosing guidance

Product information lists Sleepose 20 Tablet as likely containing 20 mg of melatonin per tablet.

Typical melatonin dosing varies; Circadin, the licensed prescription product in the UK, is a 2 mg prolonged-release tablet.

A 20 mg dose is substantially above the doses commonly prescribed, and the risk of residual sedation is higher.

Check with the prescriber before use; lower starting doses (0.5–5 mg) are used for most adults, with higher doses reserved for where clinically justified.

DT advantages and administration tips

• How to take DT: place the tablet on the tongue and allow it to dissolve; do not chew if the tablet is intended to disintegrate.
• Timing: take 30–60 minutes before bedtime for onset advantage.
• Food interactions: avoid taking with large or heavy meals as this may delay absorption.
• Practical note: keep DT in original blister until use to protect disintegration properties.

Legal status and availability in the UK

Sleepose is not licensed in the UK. Melatonin is a prescription-only medicine (POM) in the UK.

In our online pharmacy, Sleepose is available without a prescription, with discreet delivery to the United Kingdom in 9–21 days.

Safety profile and adverse effects

Common and expected effects

What side effects should patients expect?

Sleepose’s safety profile mirrors the melatonin class with common mild‑to‑moderate events such as drowsiness, headache, nausea, abdominal cramps, confusion and irritability.

Because Sleepose is likely 20 mg per tablet, there is an increased potential for daytime sedation and impaired driving the following day.

Patients often ask about interactions with alcohol and other sedatives and whether melatonin causes dependence — it is not associated with classical dependence seen with benzodiazepines but caution is still required.

Monitoring and reporting

• Do not drive or operate heavy machinery if you feel sedated the next morning.
• Avoid combining melatonin with alcohol, opioids or sedating antihistamines.
• Report severe or persistent reactions to a doctor or pharmacist.

Suspected adverse reactions can be reported via the MHRA Yellow Card scheme.

Contraindications and precautions

Absolute contraindications

Who should not use Sleepose without medical advice?

Product data notes pregnancy and breastfeeding as contraindications or situations requiring medical consultation before use.

Some guidance also lists autoimmune disease as an absolute contraindication; patients with known autoimmune conditions should seek medical advice before use.

Relative contraindications and special warnings

• Hepatic or renal impairment: dose adjustment is not specified, so consult the prescriber.
• Pre-existing depression or seizure disorders: discuss with the GP before using melatonin.
• Immunosuppressants or anticoagulants: potential interactions warrant prescriber review.

Drug interactions and medicines to avoid

Notable interactions

Which medicines increase risk when taken with melatonin?

Melatonin has both pharmacodynamic and pharmacokinetic interactions.

Pharmacodynamically, additive CNS depression occurs with benzodiazepines, opioids and sedating antihistamines.

Pharmacokinetically, CYP1A2 inhibitors such as fluvoxamine can raise melatonin levels and increase adverse effects.

Anticoagulants and antiplatelet agents may be affected and herbal products such as St John’s wort can reduce melatonin concentrations while valerian may add sedative effects.

Summary of interactions

Use in special populations

Children and adolescents

Can children take Sleepose?

Product information does not specify paediatric dosing for Sleepose, and the available data advises consulting a physician for children.

Many guidelines recommend specialist input for paediatric sleep disorders and lower doses when melatonin is indicated in children.

Do not use in children without GP or paediatrician recommendation, and explore developmental or behavioural causes of poor sleep.

Elderly, pregnant and breastfeeding patients

Elderly patients: increased sensitivity to sedative effects and greater fall risk; start at a low dose and review regularly.

Pregnancy and breastfeeding: product data lists these as contraindications or circumstances requiring medical supervision; do not use without obstetric advice.

Liver and kidney impairment: dose adjustments are not specified; consult the prescriber due to unclear pharmacokinetic data.

Comparing Sleepose with other melatonin products

Dosage and formulation differences

Sleepose 20 mg DT is a high-strength immediate-release disintegrating tablet, which contrasts with prescription Circadin (2 mg prolonged-release).

The difference in dose and release profile means Sleepose is aimed at rapid onset, while prolonged-release products aim to support sleep maintenance overnight.

Practical considerations

• A lower dose or prolonged-release melatonin is preferred for older adults and for sleep-maintenance problems.
• Circadin is a prescription option in the UK.
• Some patients prefer rapid onset for sleep latency, while others need a sustained effect through the night.

Storage, missed doses and overdose management

Storage

How should Sleepose be stored?

Store in a cool, dry place and avoid direct sunlight to preserve the formulation and disintegration properties.

Keep disintegrating tablets in their original blister until use and keep all medicines out of the reach of children.

Missed dose and overdose actions

• Missed dose: skip the missed dose and take the next scheduled dose as directed rather than double dosing.
• Overdose: seek medical attention if symptoms such as excessive drowsiness, confusion or severe vomiting occur and persist.
• Emergency advice: contact NHS 111 or local emergency services for severe symptoms and consider MHRA Yellow Card reporting for suspected overdose or serious adverse reactions.

Counselling points

• Dissolve the tablet on the tongue 30–60 minutes before bedtime.
• Warn about next-day drowsiness and driving; a lower dose may be needed.
• Tell your doctor or pharmacist about pregnancy, breastfeeding, autoimmune disease and use of other sedatives or anticoagulants.
• See the GP for persistent insomnia, new mood symptoms or suspected drug interactions.
• Store in a cool, dry place, in the original packaging and out of the reach of children.

Delivery across the United Kingdom

Common questions

1. Will it make me addicted? Melatonin is not associated with classical dependence like benzodiazepines, but recurrent use should be reviewed.
2. How soon will I feel it? Expect onset within 30–90 minutes; take it 30–60 minutes before bed.
3. Can I drive the next day? Avoid driving if you experience morning drowsiness.
4. Is 20 mg too much? Melatonin doses in the UK are typically 1–5 mg (Circadin 2 mg); 20 mg is higher than typical doses and should be discussed with a prescriber.

When in doubt, speak to a GP or pharmacist.